| UKRAIN: RESULTS OF THE PRECLINICAL AND CLINICAL STUDIES |
 |
| Chelidonium majus L. |
|
| Chelidonine |
 |
| Ukrain autofluorescence I |
 |
| Ukrain autofluorescence II |
 |
| Ukrain autofluorescence III |
 |
| Ukrain autofluorescence IV |
 |
| Ukrain autofluorescence V |
 |
| Ukrain autofluorescence VI |
 |
| Ukrain is specifically cytotoxic to tumour cells |
 |
| Ukrain in xeroderma pigmentosum I |
 |
| Ukrain in xeroderma pigmentosum II |
 |
| Results of clinical treatment with Ukrain |
 |
| Prostate cancer study in Germany |
 |
| Results of clinical treatment with Ukrain |
 |
| Survival rate in pancreatic cancer patients |
 |
| Adjuvant Ukrain therapy study |
 |
| Objectifying the subjective feeling of warmth in the tumour area |
 |
| The different influences of Ukrain on oxygen consumption |
 |
| Immunological properties of Ukrain |
 |
| Induction of apoptosis |
 |
| Results of the Ukrain Investigation at the National Cancer Institute, USA |
 |
| Results of the Ukrain Study at the National Cancer Institute, USA |
 |
| Results of the Ukrain Study at the National Cancer Institute, USA |
 |
| Inhibition of capillary sprouting by Ukrain |
 |
| Unresectable pancreas cancer (Fig.1) |
 |
| Unresecable pancreas cancer (Fig.2) |
 |
| Unresecable pancreas cancer (Fig.3) |
 |
| Ewing’s sarcoma I |
 |
| Ewing’s sarcoma II |
 |
| Small cell lung cancer |
 |
| Breast cancer |
 |
| Ukrain: Biological Mechanisms of Anti-Cancer Action |
 |
| Registrations |
 |
| S u m m a r y |
 |
| Cancer can be reversed |
 |